Health Catalyst (HCAT) Set to Announce Earnings on Tuesday: What to Expect

Health Catalyst (NASDAQ: HCAT) is a arch provider of abstracts and analytics technology and casework for healthcare organizations. The aggregation is set to advertise its antithesis for the fourth division and abounding year of 2022 on Tuesday, March 7th. In this article, we will booty a afterpiece attending at Bloom Catalyst and its business, analysis its contempo achievement and financials, and altercate what investors can apprehend from its accessible antithesis announcement.

Health Catalyst (HCAT) Set to Advertise Antithesis on Tuesday: What to Expect

Health Catalyst was founded in 2008 by a accumulation of healthcare experts, including above admiral from Intermountain Healthcare, a non-profit healthcare arrangement in Utah. The aggregation offers a apartment of abstracts and analytics articles and casework that advice healthcare organizations advance accommodating outcomes and abate costs.

Health Catalyst's articles and casework are advised to advice healthcare organizations administer and assay their clinical, financial, and operational data. Its belvedere includes accoutrement for abstracts warehousing, analytics, and achievement improvement, as able-bodied as applications for specific use cases such as citizenry bloom management, acquirement aeon management, and accommodating safety.

Health Catalyst's chump abject includes over 200 healthcare organizations above the United States, including hospitals, clinics, and added providers. The aggregation has additionally formed partnerships with above healthcare technology vendors such as Epic and Microsoft.

Recent Achievement and Financials

Health Catalyst has been growing rapidly in contempo years, apprenticed by able appeal for its articles and services. In its best contempo annual antithesis report, the aggregation appear acquirement of $65.7 million, up 40% year-over-year. Its net accident for the division was $8.2 million, or $0.23 per share, compared to a net accident of $11.8 million, or $0.44 per share, in the aforementioned aeon aftermost year.

For the abounding year of 2021, Bloom Catalyst appear acquirement of $235.2 million, up 35% year-over-year. Its net accident for the year was $32.4 million, or $0.93 per share, compared to a net accident of $51.1 million, or $1.95 per share, in 2020.

Health Catalyst's able acquirement advance has been apprenticed by both new chump accretion and amplification of its absolute chump relationships. The company's gross allowance has additionally been steadily improving, from 50.8% in 2019 to 56.4% in 2021.

In agreement of liquidity, Bloom Catalyst had banknote and banknote equivalents of $141.1 actor as of December 31, 2021, up from $91.1 actor at the end of 2020. The aggregation has no debt on its antithesis sheet.

What to Apprehend from Bloom Catalyst's Accessible Antithesis Announcement

Investors will be carefully watching Bloom Catalyst's accessible antithesis advertisement to see if the aggregation can advance its able advance trajectory. Wall Street analysts currently apprehend the aggregation to address acquirement of $75.2 actor for the fourth division of 2022, apery year-over-year advance of 24.3%. They additionally apprehend the aggregation to address a net accident of $0.14 per share.

In accession to acquirement and earnings, investors will be attractive for updates on Bloom Catalyst's chump advance and retention, as able-bodied as its artefact development and sales initiatives. The aggregation has been advance heavily in R&D and sales and business in contempo years to ammunition its growth, and investors will be attractive for signs that these investments are advantageous off.

Another breadth of absorption will be Bloom Catalyst's angle for 2022 and beyond. The aggregation has not provided specific advice for the accessible year, but administration has adumbrated that it expects to abide to abound at a able pace. In its best contempo antithesis call, CEO Dan Burton said, "We accept we are well-positioned to abide to drive advance and accomplish our abiding banking targets."

Health Catalyst's abiding banking targets accommodate accomplishing acquirement of $1 billion by 2025 and accomplishing absolute EBITDA by the end of 2022. Investors will be attractive for updates on the company's advance appear these targets, as able-bodied as any abeyant challenges or headwinds that could appulse its advance trajectory.

One abeyant accident for Bloom Catalyst is antagonism from added healthcare technology providers. The healthcare abstracts analytics bazaar is awful competitive, and there are abounding accustomed players such as Cerner Corporation, Epic Systems, and Allscripts Healthcare Solutions, as able-bodied as newer entrants such as Google and Amazon. Bloom Catalyst will charge to abide to innovate and differentiate itself in adjustment to advance its bazaar position and abide to grow.

Another accident for Bloom Catalyst is the advancing COVID-19 pandemic, which has had a cogent appulse on the healthcare industry as a whole. While the communicable has apprenticed added appeal for healthcare technology solutions, it has additionally created cogent operational and banking challenges for abounding healthcare organizations. Bloom Catalyst will charge to cross these challenges and abide to bear amount to its barter in adjustment to advance its advance trajectory.

Conclusion

Health Catalyst is a arch provider of abstracts and analytics technology and casework for healthcare organizations. The aggregation has been growing rapidly in contempo years, apprenticed by able appeal for its articles and services. While the healthcare abstracts analytics bazaar is awful aggressive and there are abeyant risks to the company's growth, Bloom Catalyst is well-positioned to abide to bear amount to its barter and accomplish its abiding banking targets.

Investors will be carefully watching Bloom Catalyst's accessible antithesis advertisement to see if the aggregation can advance its able advance trajectory. While there are no guarantees in the banal market, Bloom Catalyst's able banking achievement and abiding advance abeyant accomplish it an absorbing advance befalling for those who are accommodating to booty on some accident in the healthcare technology space.